Solatide Biosciences was established to supply analytical reference standards, research peptides, and laboratory consumables for in-vitro research use only. We source exclusively from GMP-certified, ISO 9001:2015 accredited manufacturers, price competitively, and publish documentation openly — so researchers can verify what they're working with.
Our role is to help researchers source with less uncertainty: clearer compound information, accessible documentation where available, Australian dispatch, and strict research-use-only positioning across the store.


The research peptide market is crowded with vague supplier claims and unverifiable purity statements. We don't operate that way — every purity claim we make is backed by independent third-party documentation, published openly on product pages. Every batch is subject to post-manufacturing quality control before it reaches us, with selected batches independently verified by third-party laboratories.
Quality verification follows a rigorous process:
Visit our COA & Lab Testing page for more information about our verification process.
Documentation availability, scope, and format vary by product and testing cycle.
All products sold by Solatide Biosciences are supplied strictly for in-vitro laboratory and analytical research purposes only. We make no therapeutic, diagnostic, or clinical claims, and we do not provide information for human or veterinary use.
Our commitment to research-use compliance means:

Most research peptide suppliers make purity claims that cannot be independently verified. Solatide operates differently — we source exclusively from GMP-certified, ISO 9001:2015 accredited manufacturers, subject selected batches to independent third-party analytical verification at laboratories including Janoshik and Chromate, and publish documentation directly on product pages. Batch records are organised by compound identity, strength, format, and batch reference — so researchers can review what they're working with before it arrives.
Available COA and laboratory documentation is organised through Solatide’s COA & Lab Testing page, helping researchers review batch information at the product or batch level where available.
A transparent research supply process starts with batch information researchers can review — not unsupported claims or supplier statements that cannot be verified.
Available batch documentation can be reviewed through Solatide’s COA & Lab Testing page where available.
Post-manufacturing QC and available analytical documentation help reduce reliance on supplier claims that cannot be checked.
Available analytical records are organised around compound identity, strength, format, batch references, and documentation status.
Solatide aims to keep research compounds accessible without unnecessary inflated reseller markups.
No human-use, dosing, therapeutic, cosmetic, diagnostic, or veterinary positioning across product information.
Procurement check: if a supplier cannot clearly explain batch identity, testing status, documentation availability, and intended-use restrictions, that uncertainty matters.
Every production batch undergoes post-manufacturing analytical quality control before dispatch. Manufacturer QC may include HPLC-UV purity, LC-MS identity, endotoxin, sterility, amino acid analysis, and internal release checks. If required release criteria are not met, the batch is not released.
Each production batch is subject to post-manufacturing analytical quality control before dispatch for research supply. This creates a release checkpoint after manufacturing, rather than relying only on catalogue-level supplier claims.
Release rule: if required QC checks do not meet release criteria, the batch is not released for dispatch.
Testing scope may vary by compound, batch, and relevant analytical requirements.
Used to assess chromatographic purity for relevant compounds and tested batches.
Used to support compound identity confirmation where applicable.
Included where relevant to the product type, batch, and available release documentation.
Used where relevant to support composition or identity review for applicable peptide materials.
Manufacturer release criteria are reviewed before materials proceed to research dispatch.
Available analytical documentation is connected to the relevant product or batch for online review where available.
If required QC checks do not meet release criteria, the batch is not released for dispatch.
QC may include HPLC-UV purity, LC-MS identity, endotoxin, sterility, amino acid analysis, and internal release checks depending on the product and batch.